Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $85
Hinge Health, Inc. Class A
Hinge Health, Inc. Class A HNGE | 0.00 |
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:
HNGE) with a Buy and raises the price target from $79 to $85.
